Summit Securities Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-439
| Closed | -$3.29K | – | 959 |
|
|
2025
Q1 | $3.29K | Buy |
+439
| New | +$3.29K | ﹤0.01% | 504 |
|
|
2024
Q4 | – | Sell |
-412
| Closed | -$3K | – | 517 |
|
|
2024
Q3 | $3K | Buy |
+412
| New | +$3K | ﹤0.01% | 333 |
|
|
2019
Q2 | – | Sell |
-16,255
| Closed | -$132K | – | 143 |
|
|
2019
Q1 | $132K | Buy |
+16,255
| New | +$132K | 0.02% | 95 |
|